Peterson et al., 1960 - Google Patents
Adrenocortical steroid metabolism and adrenal cortical function in liver diseasePeterson et al., 1960
View PDF- Document ID
- 18332272846478819486
- Author
- Peterson R
- et al.
- Publication year
- Publication venue
- The Journal of Clinical Investigation
External Links
Snippet
MATERIALS AND METHODS Fourteen patients with moderately severe cirrhosis of the liver, as judged by clinical signs and symptoms and liver function tests, and 3 patients with acute viral hepatitis, served as the subjects of this study. Those with cirrhosis of the liver had the …
- 230000001919 adrenal 0 title description 26
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S514/00—Drug, bio-affecting and body treating compositions
- Y10S514/899—Menstrual disorder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
- A61K51/0493—Steroids, e.g. cholesterol, testosterone
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Peterson | Adrenocortical steroid metabolism and adrenal cortical function in liver disease | |
| HELLMAN et al. | The influence of thyroid hormone on hydrocortisone production and metabolism | |
| Peterson | The influence of the thyroid on adrenal cortical function | |
| Peterson et al. | The metabolism of corticosterone in man | |
| Sandberg et al. | Studies on phenolic steroids in human subjects. II. The metabolic fate and hepato-biliary-enteric circulation of C 14-estrone and C 14-estradiol in women | |
| Sandberg et al. | Transcortin: a corticosteroid-binding protein of plasma. II. Levels in various conditions and the effects of estrogens | |
| Laragh et al. | Aldosterone secretion and primary and malignant hypertension | |
| KIRSCHNER et al. | Cushing's syndrome: nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor | |
| RICH et al. | Adrenarche: changing adrenal response to adrenocorticotropin | |
| Gabrilove et al. | Adrenocortical 11β-hydroxylase deficiency and virilism first manifest in the adult woman | |
| PETERSON et al. | Estrogens and adrenocortical function in man | |
| SANDBERG et al. | 17-HYDR0XYC0RTIC0STER0IDS AND 17-KETOSTEROIDS IN URINE OF HUMAN SUBJECTS: CLINICAL APPLICATION OF A METHOD EMPLOYING β-GLUCURONIDASE HYDROLYSIS | |
| Dohan et al. | Hormone excretion in liver disease | |
| Stege et al. | Orchidectomy or oestrogen treatment in prostatic cancer: effects on serum levels of adrenal androgens and related steroids | |
| FELBER et al. | Adrenocortical response to the 48-hour ACTH test in myxedema and hyperthyroidism | |
| Gandy et al. | Characterization of urinary steroids in adrenal hyperplasia: isolation of metabolites of cortisol, compound S, and desoxycorticosterone from a normotensive patient with adrenogenital syndrome | |
| TOURNIAIRE et al. | Male pseudohermaphroditism with hypertension due to a 17α‐hydroxylation deficiency | |
| GRANT et al. | Effects of estrogen therapy on cortisol metabolism | |
| Williams et al. | Urinary 17-ketosteroids in chronic liver disease | |
| Hsia et al. | Transformation of cortisone to cortisol in human skin | |
| David et al. | A virilizing adrenal tumor with borderline elevation of urinary 17-ketosteroids | |
| GOLD | Blood corticoids: Their Measurement and significance—a review | |
| ROBERTS et al. | 17α-hydroxypregnenolone as a precursor of urinary steroids in a patient with a virilizing adenoma of the adrenal | |
| Peterson et al. | Suppression of biosynthesis of adrenal cortical steroids in man by amphenone | |
| KEUTMANN et al. | Individual urinary 17-ketosteroids of healthy persons determined by gas chromatography: biochemical and clinical considerations |